Area of research
Hematology · Physiology
Research interest
Research interests include Immunology, Graft-versus-host disease, Immune system, Biology, Cyclophosphamide, and Medicine.
The Anti‐Human P2X7 Monoclonal Antibody (Clone L4) Can Mediate Complement‐Dependent Cytotoxicity of Human Leukocytes
Adeno‐associated viral vectors encoding anti‐P2X7 nanobodies reduce graft‐versus‐host disease in a humanised mouse model
Humanized Mouse Model of Graft-Versus-Host Disease Utilizing Nonirradiated NOD-scid-IL-2Rγnull Mice
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice
Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice
Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft‐<i>versus</i>‐host disease development in humanized mice treated with post‐transplant cyclophosphamide
Purinergic signalling in graft-versus-host disease
A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice
Insights into mechanisms of graft-versus-host disease through humanised mouse models
6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist
Preparation of the Murine Anti-Human P2X7 Receptor Monoclonal Antibody (Clone L4)
Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease
The P2X7 Receptor Antagonist AZ10606120 Does Not Alter Graft-Versus-Host Disease Development and Increases Serum Human Interferon-γ in a Humanized Mouse Model